Reversible Assembly of Proteolysis Targeting Chimeras. Academic Article uri icon

Overview

abstract

  • PROteolysis TArgeting Chimeras (PROTACs) are of significant current interest for the development of probe molecules and drug leads. However, they suffer from certain limitations. PROTACs are rule-breaking molecules with sub-optimal cellular permeability, solubility, and other drug-like properties. In particular, they exhibit an unusual dose-response curve where high concentrations of the bivalent molecule inhibit degradation activity, a phenomenon known as the hook effect. This will likely complicate their use in vivo. In this study, we explore a novel approach to create PROTACs that do not exhibit a hook effect. This is achieved by equipping the target protein and E3 ubiquitin ligase ligands with functionalities that undergo rapid and reversible covalent assembly in cellulo. We report the development of Self-Assembled Proteolysis Targeting Chimeras that mediate the degradation of the Von Hippel-Lindau E3 ubiquitin ligase and do not evince a hook effect.

publication date

  • July 9, 2023

Research

keywords

  • Proteolysis Targeting Chimera
  • Ubiquitin-Protein Ligases

Identity

Digital Object Identifier (DOI)

  • 10.1021/acschembio.3c00199

PubMed ID

  • 37422908